- In latest deal, Innovent seeds Spero's future beyond GSK-owned antibioticAfter partnering with four of the largest pharmaceutical companies over the past 18 months, Innovent Biologics is turning to a smaller partner for its next bet. An autoimmune drug candidate from…Endpoints · 14d ago↗ source
- Former Akero team announces new I&I company, Avere, with China drugEverything around China biotech really does seem to be speeding up. On Tuesday, the former executive team behind Akero Therapeutics unveiled a new company, a pipeline drug from China and a revers…Endpoints · 14d ago↗ source
- Experts: Industry to benefit from focused follow-ups, major deficiency letters in MDUFA VI<p>Industry experts say the draft commitment letter for the next Medical Device User Fee Amendments (MDUFA VI) program negotiated by the US Food and Drug Administration (FDA) and the medtech indust…